Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Livro
|
![]() |
Current Knowledge in Thyroid Cancer—From Bench to BedsideGrimm, DanielaMDPI 2017Texto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Structural Insights into Pseudokinase Domains of Receptor Tyrosine KinasesSheetz, Joshua B. ; Mathea, Sebastian ; Karvonen, Hanna ; Malhotra, Ketan ; Chatterjee, Deep ; Niininen, Wilhelmiina ; Perttilä, Robert ; Preuss, Franziska ; Suresh, Krishna ; Stayrook, Steven E. ; Tsutsui, Yuko ; Radhakrishnan, Ravi ; Ungureanu, Daniela ; Knapp, Stefan ; Lemmon, Mark A.Mol. Cell, 2020-08, Vol.79 (3), p.390-405.e7 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Mechanisms of receptor tyrosine kinase activation in cancerDu, Zhenfang ; Lovly, Christine MMolecular cancer, 2018-02, Vol.17 (1), p.58-13, Article 58 [Periódico revisado por pares]England: BioMed Central LtdTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applicationsZhu, Chenjing ; Wei, Yuquan ; Wei, XiaweiMolecular cancer, 2019-11, Vol.18 (1), p.153-22, Article 153 [Periódico revisado por pares]England: BioMed CentralTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Pexidartinib: First ApprovalLamb, Yvette N.Drugs (New York, N.Y.), 2019-11, Vol.79 (16), p.1805-1812 [Periódico revisado por pares]Cham: Springer International PublishingTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Role of Bruton's tyrosine kinase in B cells and malignanciesPal Singh, Simar ; Dammeijer, Floris ; Hendriks, Rudi WMolecular cancer, 2018-02, Vol.17 (1), p.57-57, Article 57 [Periódico revisado por pares]England: BioMed Central LtdTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Single-cell profiling guided combinatorial immunotherapy for fast-evolving CDK4/6 inhibitor-resistant HER2-positive breast cancerWang, Qingfei ; Guldner, Ian H ; Golomb, Samantha M ; Sun, Longhua ; Harris, Jack A ; Lu, Xin ; Zhang, SiyuanNature communications, 2019-08, Vol.10 (1), p.3817-12, Article 3817 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Erdafitinib in Locally Advanced or Metastatic Urothelial CarcinomaLoriot, Yohann ; Necchi, Andrea ; Park, Se Hoon ; Garcia-Donas, Jesus ; Huddart, Robert ; Burgess, Earle ; Fleming, Mark ; Rezazadeh, Arash ; Mellado, Begoña ; Varlamov, Sergey ; Joshi, Monika ; Duran, Ignacio ; Tagawa, Scott T ; Zakharia, Yousef ; Zhong, Bob ; Stuyckens, Kim ; Santiago-Walker, Ademi ; De Porre, Peter ; O’Hagan, Anne ; Avadhani, Anjali ; Siefker-Radtke, Arlene OThe New England journal of medicine, 2019-07, Vol.381 (4), p.338-348 [Periódico revisado por pares]United States: Massachusetts Medical SocietyTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Cdc-Like Kinases (CLKs): Biology, Chemical Probes, and Therapeutic PotentialMartín Moyano, Paula ; Němec, Václav ; Paruch, KamilInternational journal of molecular sciences, 2020-10, Vol.21 (20), p.7549 [Periódico revisado por pares]Switzerland: MDPI AGTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
A regimen combining the Wee1 inhibitor AZD1775 with HDAC inhibitors targets human acute myeloid leukemia cells harboring various genetic mutationsZhou, L ; Zhang, Y ; Chen, S ; Kmieciak, M ; Leng, Y ; Lin, H ; Rizzo, K A ; Dumur, C I ; Ferreira-Gonzalez, A ; Dai, Y ; Grant, SLeukemia, 2015-04, Vol.29 (4), p.807-818 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |